well yes , but the PR not good. pr can effect valuation of a village.
Printable View
Don't know what you mean by that, but we do have Flu vaccines which are regularly updated to match whichever strains are prevalent at the time.
Vaccines rely on a good immune system to react to the vaccine & teach the body to produce anti-bodies to give us complete or partial protection from particular pathogens.
Elderly people usually have weakened immune systems or are immunocompromised so their immune systems may only respond weakly to the vaccine meaning they don't work as well & give them the same high level of protection. Like all vulnerable groups, essential they have them though to provide a degree of protection.
Flu kills average of 700 people each year in NZ compared to road deaths of 340 in 2023.
The difference between SailorBoy & I are numerous & in this case we differed as well.
I have always seen the float as approximately 15% of the original sale value i.e retained DMF, plus any profit on the resale.
Targeted profit on resales is 20%.
This should generate around $60M per year, growing to around $12M per year compounding as units are sold and more resales come on stream.
The float that SailorBoy referred to only eventuates once they stop borrowing for development. I.e OCA saves the interest costs, then if they stop all development the float will grow, but that's a much longer term proposition.
REINZ data January
The total number of properties sold across New Zealand in January 2024 4.9% higher than pcp ……so volumes growing although remain at very low levels
But Auckland however lowest sales count month ever recorded (except covid months)
Maybe Brent will have to say sluggish property market holding back sales
Median price down a tad
https://www.reinz.co.nz/Web/Web/News...onfidence_lift
Sales, sales and even more sales is the cry from Oceania shareholders
But Brent probably would like to see the red line heading up faster …going up but not really conducive for booming sales
Annual house sales volumes chart updated